Inflammatory mediators gene polymorphisms in preeclampsia

Hypertension in Pregnancy

Volumn 30, Issue 3, 2011, Pages 338-346

  Franchim, Camila S ^a   Sass, Nelson ^a   Mattar, Rosiane ^a   Pendeloski, Karen P T ^a   Lin, Lawrence Hsu ^a   Torloni, Maria R ^a   Daher, Silvia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Genetic Polymorphism; Inflammatory mediators; Preeclampsia

Indexed keywords

INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 12; INTERLEUKIN 18; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-12; INTERLEUKIN-18; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, INTERLEUKIN-1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 79960161539     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903455389     Document Type: Article

References (53)

1. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 2003; 24(Suppl A):S21-S27. (Pubitemid 37184731)
2. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med 2007; 28:192-209. (Pubitemid 46843191)
3. Guven MA, Coskun A, Ertas IE, Aral M, Zencirci B, Oksuz H. Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy 2009; 28:190-200.
4. von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002; 81:642-648. (Pubitemid 34830401)
5. Lockwood CJ, Matta P, Krikun G, et al. Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am J Pathol 2006; 168:445-452. (Pubitemid 43271143)
6. Ledee N, Dubanchet S, Oger P, et al. Uterine receptivity and cytokines: new concepts and new applications. Gynecol Obstet Invest 2007; 64:138-143. (Pubitemid 47574872)
7. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19:423-474. (Pubitemid 32368042)
8. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 2004; 11:405-410. (Pubitemid 39491434)
9. Bachmayer N, Rafik HR, Liszka L, Bremme K, Sverremark-Ekstrom E. Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol 2006; 56:292-301. (Pubitemid 44669325)
10. Jonsson Y, Ruber M, Matthiesen L, et al. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70:83-91.
11. Sakai M, Shiozaki A, Sasaki Y, Yoneda S, Saito S. The ratio of interleukin (IL)-18 to IL-12 secreted by peripheral blood mononuclear cells is increased in normal pregnant subjects and decreased in pre-eclamptic patients. J Reprod Immunol 2004; 61:133-143. (Pubitemid 38446986)
12. Koga K, Mor G. Expression and function of toll-like receptors at the maternal-fetal interface. Reprod Sci 2008; 15:231-242. (Pubitemid 351550944)
13. Patni S, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA. Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod 2009; 80:243-248.
14. Kim YM, Romero R, Oh SY, et al. Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? Am J Obstet Gynecol 2005; 193:921-927.
15. Mazouni C, Capo C, Ledu R, et al. Preeclampsia: impaired inflammatory response mediated by Toll-like receptors. J Reprod Immunol 2008; 78:80-83. (Pubitemid 351609121)
16. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun 2001; 2:61-70. (Pubitemid 33674230)
17. He G, Liu X, Fan P, et al. The C825T polymorphism in the G-protein beta 3 subunit gene in Chinese patients with preeclampsia. Hypertens Pregnancy 2009; 28:156-167.
18. Daher S, Sass N, Oliveira LG, Mattar R. Cytokine genotyping in preeclampsia. Am J Reprod Immunol 2006; 55:130-135. (Pubitemid 43329488)
19. Freeman DJ, McManus F, Brown EA, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44:708-714. (Pubitemid 39435242)
20. Kaiser T, Grehan M, Brennecke SP, Moses EK. Association of the TNF2 allele with eclampsia. Gynecol Obstet Invest 2004; 57:204-209. (Pubitemid 38608331)
21. NHBPEP. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
22. Gustincich S, Manfioletti G, Del SG, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11:298-300, 302.
23. Bergholdt R, Karlsen AE, Johannesen J, et al. Characterization of polymorphisms of an interleukin 1 receptor type 1 gene (IL1RI) promotor region (P2) and their relation to insulindependent diabetes mellitus (IDDM). The Danish Study Group of Diabetes in Childhood. Cytokine 1995; 7:727-733.
24. Hall MA, McGlinn E, Coakley G, et al. Genetic polymorphism of IL-12 p40 gene in immunemediated disease. Genes Immun 2000; 1:219-224.
25. Nogueira E, Ozaki KS, Macusso GD, Quarim RF, Camara NO, Pacheco-Silva A. Incidence of donor and recipient toll-like receptor-4 polymorphisms in kidney transplantation. Transplant Proc 2007; 39:412-414. (Pubitemid 46386246)
26. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989 11; 17:2503-2516. (Pubitemid 19103235)
27. Ogus AC, Yoldas B, Ozdemir T, et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 23:219-223. (Pubitemid 38195506)
28. Kretowski A, Mironczuk K, Karpinska A, et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002; 51:3347-3349. (Pubitemid 35246985)
29. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 11:116-128. (Pubitemid 20136185)
30. Hamann L, Gomma A, Schroder NW, et al. A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J Mol Med 2005; 83:478-485. (Pubitemid 40922170)
31. Hirankarn N, Tangwattanachuleeporn M, Wongpiyabovorn J, Wongchinsri J, Avihingsanon Y. Association of IL-18 gene polymorphism (?137C) with arthritis manifestations in SLE: combined effect with IFN gamma gene polymorphism (+874A). Clin Rheumatol 2009; 28:219-223.
32. Reiner AP, Wurfel MM, Lange LA, et al. Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol 2008; 28:1407-1412.
33. Rey G, Skowronek F, Alciaturi J, Alonso J, Bertoni B, Sapiro R. Toll receptor 4 Asp299Gly polymorphism and its association with preterm birth and premature rupture of membranes in a South American population. Mol Hum Reprod 2008; 14:555-559.
34. Seol HJ, Lee ES, Jung SE, et al. Serum levels of YKL-40 and interleukin-18 and their relationship to disease severity in patients with preeclampsia. J Reprod Immunol 2009; 79:183-187.
35. Stassen NA, Breit CM, Norfleet LA, Polk HC Jr. IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery 2003; 134:351-356. (Pubitemid 37070360)
36. Tang F, Liu W, Zhang F, et al. IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese. PLoS ONE 2008; 3:e2183.
37. Molvarec A, Jermendy A, Kovacs M, Prohaszka Z, Rigo J, Jr. Toll-like receptor 4 gene polymorphisms and preeclampsia: lack of association in a Caucasian population. Hypertens Res 2008; 31:859-864. (Pubitemid 351895029)
38. van Rijn BB, Franx A, Steegers EA, et al. Maternal TLR4 and NOD2 gene variants, proinflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome. PLoS ONE 2008; 3:e1865.
39. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http:// www.allelefrequencies.net. Tissue Antigens 2003; 61:403-407. (Pubitemid 36605674)
40. DAmora P, Sato H, Girao MJ, Silva ID, Schor E. Polymorphisms in exons 1B and 1C of the type I interleukin-1 receptor gene in patients with endometriosis. Am J Reprod Immunol 2006; 56:178-184. (Pubitemid 44159215)
41. Levrant S, Coulam CB, Jeyendran RS. Interleukin 1 receptor antagonist gene polymorphisms are not risk factors for recurrent pregnancy loss: evaluation of couples. Am J Reprod Immunol 2008; 60:224-228.
42. Faisel F, Romppanen EL, Hiltunen M, et al. Polymorphism in the interleukin 1 receptor antagonist gene in women with preeclampsia. J Reprod Immunol 2003; 60:61-70. (Pubitemid 37272296)
43. Hefler LA, Tempfer CB, Gregg AR. Polymorphisms within the interleukin-1 beta gene cluster and preeclampsia. Obstet Gynecol 2001; 97:664-668.
44. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G. A TaqI polymorphism in the 3?UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002; 3:419-423. (Pubitemid 41656541)
45. Han SS, Cho EY, Lee TS, et al. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women. Eur J Obstet Gynecol Reprod Biol 2008; 140:71-75.
46. Ostojic S, Volk M, Medica I, Kapovic M, Meden-Vrtovec H, Peterlin B. Polymorphisms in the interleukin-12/18 genes and recurrent spontaneous abortion. Am J Reprod Immunol 2007; 58:403-408. (Pubitemid 47534850)
47. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007 1; 178:5949-5956. (Pubitemid 46674392)
48. Bushley AW, Ferrell R, McDuffie K, et al. Polymorphisms of interleukin (IL)-1alpha, IL- 1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 2004; 95:672-679. (Pubitemid 39592536)
49. Kashef MA, Dehaghani AS, Naeimi S, Fattahi MJ, Ghaderi A. Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases. J Reprod Med 2008; 53:853-859.
50. Genc MR, Vardhana S, Delaney ML, et al. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol 2004; 116:152-156. (Pubitemid 39195125)
51. Hirschfeld AF, Jiang R, Robinson WP, McFadden DE, Turvey SE. Toll-like receptor 4 polymorphisms and idiopathic chromosomally normal miscarriage. Hum Reprod 2007; 22:440-443. (Pubitemid 46152565)
52. Krediet TG, Wiertsema SP, Vossers MJ, et al. Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res 2007; 62:474-476. (Pubitemid 47476208)
53. Molvarec A, Jermendy A, Nagy B, et al. Association between tumor necrosis factor (TNF)- alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clin Chim Acta 2008; 392:52-57.